ArticleBMC anesthesiology2026
Anesthetic management and obstetric outcome for open fetal myelomeningocele repair at a Japanese center: a retrospective cohort study.
Article in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOpen fetal surgery for myelomeningocele (MMC) is an established treatment internationally, but remains new and rarely performed in Asia. This study aimed to describe our anesthetic management and obstetric outcomes of this procedure in Japanese patients, with a particular focus on preterm birth (PTB).
methodsWe retrospectively reviewed 10 cases of open fetal MMC repair at our institution between April 2021 and April 2025. Anesthetic management, intraoperative uterine relaxation, maternal hemodynamic control, and perinatal outcome were descriptively analyzed.
resultsPTB occurred in 5 cases (50%): 4 due to preterm labor and 1 due to preterm premature rupture of membranes. One case was delivered before 30 weeks, none between 30 and 34 weeks, and 4 between 34 and 37 weeks. Uterine relaxation was achieved using desflurane at a mean of 2.3 minimum alveolar concentration (MAC). Hypotension was managed with norepinephrine equivalent (NEE) scale (median maximum dose 0.13 µg/kg/min). Magnesium sulfate was reduced from 6 g to 4 g in the latter half of cases after high serum levels (up to 9.1 mg/dL) were observed. The PTB rate decreased from 60% in the first five cases to 40% in the latter five.
conclusionsOpen fetal MMC repair was feasible in this population under a standardized anesthetic approach, with acceptable maternal and obstetric outcomes. Individualized drug dosing and objective assessment of uterine relaxation may further improve safety. Our findings may serve as a reference for institutions introducing fetal surgery in Japan; however, they should be interpreted with caution due to the small sample size.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.